<div id="readability-page-1"><div><p>As global markets navigate the complexities of Middle East tensions and energy market volatility, major U.S. stock indexes have shown resilience, with the Nasdaq Composite leading gains amidst a backdrop of mixed labor data and tentative geopolitical de-escalation. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate robust adaptability to shifting economic conditions and possess innovative capabilities that can thrive even amid broader market uncertainties.</p><h3>Top 10 High Growth Tech Companies Globally</h3><div><table><tbody><tr><th>Name</th><th>Revenue Growth</th><th>Earnings Growth</th><th>Growth Rating</th></tr><tr><td>Hacksaw</td><td>24.17%</td><td>25.33%</td><td>★★★★★★</td></tr><tr><td>Giant Network Group</td><td>36.46%</td><td>42.98%</td><td>★★★★★★</td></tr><tr><td>Shengyi TechnologyLtd</td><td>24.24%</td><td>32.49%</td><td>★★★★★★</td></tr><tr><td>Suzhou TFC Optical Communication</td><td>43.76%</td><td>38.73%</td><td>★★★★★★</td></tr><tr><td>Zhongji Innolight</td><td>35.32%</td><td>37.30%</td><td>★★★★★★</td></tr><tr><td>Shengyi Electronics</td><td>26.92%</td><td>36.01%</td><td>★★★★★★</td></tr><tr><td>Unimicron Technology</td><td>21.22%</td><td>69.47%</td><td>★★★★★★</td></tr><tr><td>Co-Tech Development</td><td>34.37%</td><td>65.79%</td><td>★★★★★★</td></tr><tr><td>Suzhou Dongshan Precision Manufacturing</td><td>36.66%</td><td>84.97%</td><td>★★★★★★</td></tr><tr><td>CARsgen Therapeutics Holdings</td><td>64.21%</td><td>83.56%</td><td>★★★★★★</td></tr></tbody></table></div><p>Click here to see the full list of 199 stocks from our Global High Growth Tech and AI Stocks screener.</p><p>We'll examine a selection from our screener results.</p><h2>Pharming Group (ENXTAM:PHARM)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p><p><strong>Overview:</strong> Pharming Group N.V. is a biopharmaceutical company focused on developing and commercializing protein replacement therapies and precision medicines for rare diseases across the United States, Europe, and other international markets, with a market cap of €1.01 billion.</p><p><strong>Operations:</strong> Pharming Group generates revenue primarily from its products Ruconest® and Joenja®, with Ruconest® contributing $317.92 million and Joenja® $58.21 million. The company focuses on therapies for rare diseases, serving markets in the United States, Europe, and internationally.</p><p>Pharming Group's recent strides in biotechnology underscore its potential within the high-growth tech sector, particularly following CHMP's positive opinion on Joenja® for treating APDS, setting the stage for a pivotal EC decision. This development complements their financial upturn, with 2025 witnessing a revenue jump to $376 million from $297 million in 2024 and a swing to net profits of $2.85 million from a prior loss. R&amp;D efforts remain robust, critical for sustaining innovation and market competitiveness in rare disease treatments. These factors collectively highlight Pharming's trajectory towards leveraging scientific advancements into commercially viable solutions, enhancing its footprint in specialized healthcare markets.</p><ul><li>Unlock comprehensive insights into our analysis of Pharming Group stock in this health report.</li><li>Gain insights into Pharming Group's past trends and performance with our Past report.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0b975b67-eb09-4f0d-a0c0-7a08bd4f1141/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0b975b67-eb09-4f0d-a0c0-7a08bd4f1141/chart/revenue-and-expenses-breakdown"/><figcaption>ENXTAM:PHARM Revenue and Expenses Breakdown as at Apr 2026</figcaption></figure><h2>Ruijie Networks (SZSE:301165)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★★</p><p><strong>Overview:</strong> Ruijie Networks Co., Ltd. is involved in the design, research, and sale of network equipment, network security products, and cloud desktop solutions both in China and internationally, with a market capitalization of CN¥64.14 billion.</p><p><strong>Operations:</strong> Ruijie Networks generates revenue primarily from network equipment, contributing CN¥12.52 billion, followed by cloud desktop solutions and cyber security products at CN¥572.88 million and CN¥493.72 million, respectively.</p><p>Ruijie Networks has demonstrated robust financial growth, with a notable increase in revenue from CNY 11.7 billion to CNY 14.3 billion and net income rising from CNY 574 million to CNY 696 million over the past year. This performance is underpinned by a significant annual earnings growth rate of 36.7%, outpacing the Communications industry's average by over 10%. The company's commitment to innovation is evident in its strategic R&amp;D investments, crucial for maintaining competitive advantage in the rapidly evolving tech landscape. With earnings projected to grow by an impressive annual rate of approximately 36% over the next three years, Ruijie Networks is well-positioned to capitalize on market opportunities and expand its technological offerings further.</p><ul><li>Delve into the full analysis health report here for a deeper understanding of Ruijie Networks.</li><li>Assess Ruijie Networks' past performance with our detailed historical performance reports.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a0c69abc-cd2d-4e42-9326-ee1a888b1f87/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a0c69abc-cd2d-4e42-9326-ee1a888b1f87/chart/earnings-and-revenue-growth"/><figcaption>SZSE:301165 Earnings and Revenue Growth as at Apr 2026</figcaption></figure><h2>Dexerials (TSE:4980)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Dexerials Corporation, with a market cap of ¥362.53 billion, specializes in the production and sale of electronic components, bonding materials, and optics materials primarily in Japan.</p><p><strong>Operations:</strong> The company generates revenue through its Optical Materials and Components segment, which contributes ¥46.62 billion, and the Electronic Materials and Components segment, bringing in ¥64.73 billion.</p><p>Dexerials Corporation, amid a challenging landscape, has managed to maintain steady revenue growth at 8.9% annually. This performance is particularly noteworthy given the slight dip in net income from JPY 23.36 billion to JPY 21.27 billion over the last nine months of reporting, reflecting robust operational resilience. The firm's commitment to innovation is mirrored in its R&amp;D spending which remains a critical aspect of its strategy, aiming to foster advancements and maintain competitiveness in the tech sector where continuous evolution is paramount.</p><ul><li>Take a closer look at Dexerials' potential here in our health report.</li><li>Examine Dexerials' past performance report to understand how it has performed in the past.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/95dbf7fd-a146-474e-9a1b-14bf2984e6ca/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/95dbf7fd-a146-474e-9a1b-14bf2984e6ca/chart/earnings-and-revenue-growth"/><figcaption>TSE:4980 Earnings and Revenue Growth as at Apr 2026</figcaption></figure><h2>Summing It All Up</h2><ul><li>Click here to access our complete index of 199 Global High Growth Tech and AI Stocks.</li><li>Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.</li><li>Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.</li></ul><h2>Searching for a Fresh Perspective?</h2><ul><li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li><li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li><li>Find companies with promising cash flow potential yet trading below their fair value.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation. We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.</em></p><div><h3><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>• Connect an unlimited number of Portfolios and see your total in one currency<br/>• Be alerted to new Warning Signs or Risks via email or mobile<br/>• Track the Fair Value of your stocks<br/></p><p>Try a Demo Portfolio for Free</p></div></div></div>

IUSG

<p>As global markets face Middle East tensions and energy volatility, U.S. stock indexes, particularly the Nasdaq Composite, show resilience. High growth tech stocks are highlighted, including Pharming Group, Ruijie Networks, and Dexerials, each demonstrating strong revenue and earnings growth. Pharming focuses on rare disease therapies, Ruijie excels in network solutions, and Dexerials specializes in electronic components. These companies are well-positioned for future growth amid market uncertainties, showcasing adaptability and innovation in their respective sectors.</p>

- Major U.S. stock indexes are exhibiting resilience amidst Middle East tensions and energy market volatility, with the Nasdaq Composite leading gains. 
- High growth tech companies like Pharming Group and Ruijie Networks show strong adaptability, with Pharming achieving significant revenue growth and R&D investment, and Ruijie Networks reporting an impressive increase in earnings. 
- The landscape highlights the importance of innovation and strategic investments for sustaining growth in the tech sector amid market uncertainties.

High Growth Tech Stocks To Watch In April 2026